FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Erin Karschner

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Dayong Lee; Garry Milman; Allan J Barnes; Robert S Goodwin; Erin L Karschner; Marilyn A Huestis
Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
Mateus M Bergamaschi; Robert S Goodwin; Jussi Hirvonen; Erin L Karschner; Regina H C Queiroz; Karl B Scheidweiler; Marilyn A Huestis
Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws.
Wendy M Bosker; Robert S Goodwin; Jussi Hirvonen; Marilyn A Huestis; Robert B Innis; Erin L Karschner; Kim P C Kuypers; Dayong Lee; Eef L Theunissen; Johannes G Ramaekers
Psychomotor function in chronic daily Cannabis smokers during sustained abstinence.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Erin Karschner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Dayong Lee; Garry Milman; Allan J Barnes; Robert S Goodwin; Erin L Karschner; Marilyn A Huestis
Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
Drug and alcohol dependence 2013;130(1-3):68-76.
2013: Mateus M Bergamaschi; Robert S Goodwin; Jussi Hirvonen; Erin L Karschner; Regina H C Queiroz; Karl B Scheidweiler; Marilyn A Huestis
Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws.
Clinical chemistry 2013;59(3):519-26.
2013: Wendy M Bosker; Robert S Goodwin; Jussi Hirvonen; Marilyn A Huestis; Robert B Innis; Erin L Karschner; Kim P C Kuypers; Dayong Lee; Eef L Theunissen; Johannes G Ramaekers
Psychomotor function in chronic daily Cannabis smokers during sustained abstinence.
PloS one 2013;8(1):e53127.
2012: Erin L Karschner; Deanna L Kelly; Eugene W Schwilke; David M Schwope; Robert S Goodwin; David A Gorelick; Marilyn A Huestis
Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC.
Drug and alcohol dependence 2012;125(3):313-9.
2011: David M Schwope; Erin L Karschner; David A Gorelick; Marilyn A Huestis
Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.
Clinical chemistry 2011;57(10):1406-14.
2011: Erin L Karschner; William D Darwin; Robert P McMahon; F Liu; S Wright; R S Goodwin; Marilyn A Huestis
Subjective and physiological effects after controlled Sativex and oral THC administration.
Clinical pharmacology and therapeutics 2011;89(3):400-7.
2011: Erin L Karschner; William D Darwin; Robert S Goodwin; Stephen Wright; Marilyn A Huestis
Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration.
Clinical chemistry 2011;57(1):66-75.
2010: Erin L Karschner; Allan J Barnes; Ross H Lowe; Karl B Scheidweiler; Marilyn A Huestis
Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma.
Analytical and bioanalytical chemistry 2010;397(2):603-11.
2009: Eugene W Schwilke; David M Schwope; Erin L Karschner; Ross H Lowe; William D Darwin; Deanna L Kelly; Robert S Goodwin; David A Gorelick; Marilyn A Huestis
Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.
Clinical chemistry 2009;55(12):2180-9.
2009: Erin L Karschner; Eugene W Schwilke; Ross H Lowe; W David Darwin; Harrison G Pope; Ronald I Herning; Jean L Cadet; Marilyn A Huestis
Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?
Addiction (Abingdon, England) 2009;104(12):2041-8.
2009: Erin L Karschner; Eugene W Schwilke; Ross H Lowe; William D Darwin; Ronald I Herning; Jean Lud Cadet; Marilyn A Huestis
Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.
Journal of analytical toxicology 2009;33(8):469-77.
2009: Eugene W Schwilke; Erin L Karschner; Ross H Lowe; Ann M Gordon; Jean Lud Cadet; Ronald I Herning; Marilyn A Huestis
Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing.
Clinical chemistry 2009;55(6):1188-95.
2007: Ross H Lowe; Erin L Karschner; Eugene W Schwilke; Allan J Barnes; Marilyn A Huestis
Simultaneous quantification of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry.
Journal of chromatography. A 2007;1163(1-2):318-27.
2006: Kathleen M Dorgan; Whitney L Wooderchak; Donraphael P Wynn; Erin L Karschner; Joshua F Alfaro; Yinqiu Cui; Zhaohui Sunny Zhou; Joan M Hevel
An enzyme-coupled continuous spectrophotometric assay for S-adenosylmethionine-dependent methyltransferases.
Analytical biochemistry 2006;350(2):249-55.
2004: Joshua F Alfaro; Tiao Zhang; DonRaphael P Wynn; Erin L Karschner; Zhaohui Sunny Zhou
Synthesis of LuxS inhibitors targeting bacterial cell-cell communication.
Organic letters 2004;6(18):3043-6.